CBUSF
UTHR icon

Construction & Building Unions Superannuation Fund’s United Therapeutics UTHR Stock Holding History

Construction & Building Unions Superannuation Fund’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.2M Sell
26,223
-360
-1% -$203K 0.25% 83
2026
Q1 		$15.8M Hold
26,583
– – 0.3% 77
2025
Q4 		$13M Buy
+26,583
New +$12.4M 0.18% 90

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Construction & Building Unions Superannuation Fund's UTHR Position: Q2 2026 in Review

Construction & Building Unions Superannuation Fund reduced its United Therapeutics (UTHR) stake by 1.4% in Q2 2026, selling an estimated $203K and leaving 26,223 shares worth $14.2M. The position accounts for 0.25% of the portfolio, ranked #83.

Construction & Building Unions Superannuation Fund first reported a position in UTHR in Q4 2025 and has held it in 3 quarters since. The position peaked at $15.8M in Q1 2026. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Construction & Building Unions Superannuation Fund held 26,223 shares of United Therapeutics worth $14.2M as of Q2 2026.
  • Construction & Building Unions Superannuation Fund sold 360 United Therapeutics shares in Q2 2026, an estimated $203K.
  • United Therapeutics made up 0.25% of Construction & Building Unions Superannuation Fund's portfolio in Q2 2026, its #83 holding.
  • Construction & Building Unions Superannuation Fund first reported a position in United Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Construction & Building Unions Superannuation Fund's United Therapeutics position peaked at $15.8M in Q1 2026.
  • 882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Construction & Building Unions Superannuation Fund's 13F filing for Q2 2026, filed 6 Aug 2026.